Anthrax Company NPR's Steve Inskeep reports on BioPort, the only company holding a contract to produce a vaccine for anthrax. The company is in financial trouble, and it appears unlikely it will be able to meet the Defense Department demand for millions of doses of the vaccine, used to protect U.S. service personnel from the possibility of biological warfare.
NPR logo

Anthrax Company

Only Available in Archive Formats.
Anthrax Company

Anthrax Company

Anthrax Company

Only Available in Archive Formats.

NPR's Steve Inskeep reports on BioPort, the only company holding a contract to produce a vaccine for anthrax. The company is in financial trouble, and it appears unlikely it will be able to meet the Defense Department demand for millions of doses of the vaccine, used to protect U.S. service personnel from the possibility of biological warfare.